We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
+19.32%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$1.01B
AUM Growth
+$200M
Cap. Flow
+$77.7M
Cap. Flow %
7.68%
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ALDR
Alder Biopharmaceuticals
ALDR
+$45.1M
2
AKBA icon
Akebia Therapeutics
AKBA
+$36.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 55.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$654B
$303M 29.98%
2,979,100
– –
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$292M 28.86%
6,896,819
– –
VGK icon
3
Vanguard FTSE Europe ETF
VGK
$30B
$126M 12.46%
2,101,000
– –
INGN icon
4
Inogen
INGN
$167M
$122M 12.09%
5,419,449
– –
ALDR
5
DELISTED
Alder Biopharmaceuticals
ALDR
$64.2M 6.35%
+3,201,183
New +$45.1M
AKBA icon
6
Akebia Therapeutics
AKBA
$327M
$42.1M 4.17%
+1,516,387
New +$36.5M
FLXN
7
DELISTED
Flexion Therapeutics, Inc.
FLXN
$24M 2.38%
1,783,131
– –
WMGI
8
DELISTED
Wright Medical Group Inc
WMGI
$18.4M 1.82%
585,759
– –
TTPH
9
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$12.1M 1.2%
45,000
– –

Similar funds

HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Novo Holdings A/S's Q2 2014 Portfolio in Review

As of Q2 2014, Novo Holdings A/S held 10 positions worth $1.01B, up 25% from $811M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Novo Holdings A/S deployed $77.7M of net new capital in Q2 2014, opening 2 new positions. Its largest new stake was Alder Biopharmaceuticals: 3,201,183 shares worth $64.2M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 47% a quarter earlier.

  • Novo Holdings A/S's largest Q2 2014 buy was Alder Biopharmaceuticals: 3,201,183 shares worth $64.2M.
  • Novo Holdings A/S's ten largest holdings make up 100% of its $1.01B portfolio in Q2 2014.
  • Novo Holdings A/S opened 2 new positions and closed 0 in Q2 2014.
  • Novo Holdings A/S's portfolio value rose 25% quarter-over-quarter to $1.01B.

Based on Novo Holdings A/S's 13F filing for Q2 2014, filed 14 Aug 2014.